Page last updated: 2024-10-15

5'-o-tritylinosine

Description

5'-O-tritylinosine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135526599
CHEMBL ID386148
SCHEMBL ID18044398
MeSH IDM0502746

Synonyms (9)

Synonym
9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(trityloxymethyl)oxolan-2-yl]-3h-purin-6-one
5''-o-tritylinosine
bdbm50194172
5'-o-tritylinosine
CHEMBL386148 ,
SCHEMBL18044398
AC-32250
4152-77-6
9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(trityloxymethyl)oxolan-2-yl]-1h-purin-6-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Thymidine phosphorylaseEscherichia coli K-12IC50 (µMol)44.00000.00271.79146.5000AID1055576
Thymidine phosphorylaseHomo sapiens (human)IC50 (µMol)48.50000.02001.58386.8000AID1055577; AID270128
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
DNA damage responseThymidine phosphorylaseEscherichia coli K-12
pyrimidine nucleobase metabolic processThymidine phosphorylaseEscherichia coli K-12
pyrimidine nucleoside metabolic processThymidine phosphorylaseEscherichia coli K-12
thymidine metabolic processThymidine phosphorylaseEscherichia coli K-12
mitochondrial genome maintenanceThymidine phosphorylaseHomo sapiens (human)
angiogenesisThymidine phosphorylaseHomo sapiens (human)
pyrimidine nucleobase metabolic processThymidine phosphorylaseHomo sapiens (human)
pyrimidine nucleoside metabolic processThymidine phosphorylaseHomo sapiens (human)
chemotaxisThymidine phosphorylaseHomo sapiens (human)
signal transductionThymidine phosphorylaseHomo sapiens (human)
cell differentiationThymidine phosphorylaseHomo sapiens (human)
regulation of myelinationThymidine phosphorylaseHomo sapiens (human)
dTMP catabolic processThymidine phosphorylaseHomo sapiens (human)
regulation of transmission of nerve impulseThymidine phosphorylaseHomo sapiens (human)
regulation of gastric motilityThymidine phosphorylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
1,4-alpha-oligoglucan phosphorylase activityThymidine phosphorylaseEscherichia coli K-12
thymidine phosphorylase activityThymidine phosphorylaseEscherichia coli K-12
glycosyltransferase activityThymidine phosphorylaseEscherichia coli K-12
pentosyltransferase activityThymidine phosphorylaseEscherichia coli K-12
1,4-alpha-oligoglucan phosphorylase activityThymidine phosphorylaseHomo sapiens (human)
protein bindingThymidine phosphorylaseHomo sapiens (human)
growth factor activityThymidine phosphorylaseHomo sapiens (human)
thymidine phosphorylase activityThymidine phosphorylaseHomo sapiens (human)
protein homodimerization activityThymidine phosphorylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
cytosolThymidine phosphorylaseEscherichia coli K-12
membraneThymidine phosphorylaseEscherichia coli K-12
cytosolThymidine phosphorylaseEscherichia coli K-12
cytosolThymidine phosphorylaseHomo sapiens (human)
cytosolThymidine phosphorylaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID757782Antiviral activity against DENV serotype 2 NGC infected in mosquito C6/36 cells assessed as inhibition of virus-induced cytopathic effect after 1 week2013European journal of medicinal chemistry, Jul, Volume: 65In search of flavivirus inhibitors: evaluation of different tritylated nucleoside analogues.
AID1055577Non competitive inhibition of human recombinant thymidine phosphorylase using thymidine as substrate after 20 to 60 mins by HPLC analysis2013European journal of medicinal chemistry, , Volume: 70Fragment-based approach to the design of 5-chlorouracil-linked-pyrazolo[1,5-a][1,3,5]triazines as thymidine phosphorylase inhibitors.
AID1055576Noncompetitive inhibition of GST-tagged Escherichia coli recombinant thymidine phosphorylase expressed in Escherichia coli using thymidine as substrate after 20 to 60 mins by HPLC analysis2013European journal of medicinal chemistry, , Volume: 70Fragment-based approach to the design of 5-chlorouracil-linked-pyrazolo[1,5-a][1,3,5]triazines as thymidine phosphorylase inhibitors.
AID270130Inhibition of TPase-induced angiogenesis in chick chorioallantoic membrane at 100 nmol2006Journal of medicinal chemistry, Sep-07, Volume: 49, Issue:18
5'-O-tritylinosine and analogues as allosteric inhibitors of human thymidine phosphorylase.
AID757778Cytotoxicity against african green monkey Vero cells after 1 week2013European journal of medicinal chemistry, Jul, Volume: 65In search of flavivirus inhibitors: evaluation of different tritylated nucleoside analogues.
AID757780Cytotoxicity against mosquito C6/36 cells after 1 week2013European journal of medicinal chemistry, Jul, Volume: 65In search of flavivirus inhibitors: evaluation of different tritylated nucleoside analogues.
AID270128Inhibition of human TPase in presence of 100 uM thymidine2006Journal of medicinal chemistry, Sep-07, Volume: 49, Issue:18
5'-O-tritylinosine and analogues as allosteric inhibitors of human thymidine phosphorylase.
AID757779Antiviral activity against YFV 17D infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 1 week2013European journal of medicinal chemistry, Jul, Volume: 65In search of flavivirus inhibitors: evaluation of different tritylated nucleoside analogues.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]